Loading organizations...
Soundbite Medical Solutions develops medical devices for vascular conditions, focusing on calcified arterial lesions. Its SoundBite Crossing System uses proprietary shockwave energy delivered via a wire-based device. This technology enables physicians to recanalize severely calcified blockages and chronic total occlusions in peripheral arteries, an approach for cases resistant to conventional methods.
Louis-Philippe Riel founded Soundbite Medical Solutions in 2013, driven by the need for effective treatment of heavily calcified arterial obstructions. Riel recognized existing therapies struggled to clear these difficult-to-cross lesions, impeding blood flow. It provides a more efficient and safer solution for vascular recanalization procedures.
Soundbite Medical Solutions serves interventional cardiologists and radiologists treating peripheral artery disease patients with advanced calcification. Its vision focuses on enhancing therapeutic outcomes by developing its shockwave technology platform. Through innovation, Soundbite aims to improve procedural success and elevate quality of life for patients with complex vascular calcifications.
Soundbite Medical Solutions has raised $5.0M across 1 funding round.
Soundbite Medical Solutions has raised $5.0M in total across 1 funding round.
Soundbite Medical Solutions has raised $5.0M in total across 1 funding round.
Soundbite Medical Solutions's investors include BDC Venture Capital.
SoundBite Medical Solutions is a medical devices company developing and commercializing proprietary wire-based devices and generator technology for vascular interventions.[1][2] It focuses on innovative solutions for treating calcified coronary and peripheral artery disease, addressing challenges in vascular recanalization by enabling safer and more effective crossing of chronic total occlusions.[2][3] The company serves interventional cardiologists and vascular specialists, solving the problem of difficult-to-treat calcified blockages that complicate procedures like angioplasty and stenting. Growth momentum includes strategic licensing deals, such as an exclusive agreement with VFLO Medical for its SoundBite Crossing System and Active Vacuum technology in China.[4]
SoundBite Medical Solutions emerged from university laboratory research, where its core vascular recanalization technology was initially developed.[3] The company was formed to commercialize this innovation, transitioning academic breakthroughs into practical medical devices for real-world use.[3] Key early traction stems from partnerships like Admare Bio, which supported its build-out as a medtech startup.[1] Pivotal moments include advancing proprietary wire-based systems and generators to market-ready stages, culminating in international licensing such as the 2023 deal with VFLO Medical for expansion into China.[4]
SoundBite rides the wave of advancing interventional cardiology and peripheral vascular therapies, where rising incidences of calcified artery disease—driven by aging populations and diabetes—demand better tools for complex lesions.[2] Timing aligns with market forces favoring minimally invasive devices amid growing procedure volumes (e.g., percutaneous coronary interventions exceeding millions annually worldwide). It influences the ecosystem by licensing tech to regional players like VFLO, fostering Asia-Pacific adoption and validating its IP for potential broader partnerships or acquisitions by majors like Boston Scientific or Medtronic.[4]
Next steps likely involve scaling commercialization of its Crossing System post-China licensing, pursuing FDA approvals or CE marks for full U.S./EU launches, and expanding the pipeline for additional coronary/peripheral indications.[4] Trends like AI-guided imaging integration and bioresorbable scaffolds will shape its path, enhancing precision in calcified cases. SoundBite's influence may evolve through buyouts or alliances, solidifying its role as a key innovator in tackling stubborn vascular challenges—echoing its university origins to transform tough interventions into routine successes.[1][3]
Soundbite Medical Solutions has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Seed in October 2016.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2016 | $5.0M Seed | BDC Venture Capital |